Details for New Drug Application (NDA): 020933
✉ Email this page to a colleague
The generic ingredient in VIRAMUNE is nevirapine. There are twenty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the nevirapine profile page.
Summary for 020933
Tradename: | VIRAMUNE |
Applicant: | Boehringer Ingelheim |
Ingredient: | nevirapine |
Patents: | 0 |
Suppliers and Packaging for NDA: 020933
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VIRAMUNE | nevirapine | SUSPENSION;ORAL | 020933 | NDA | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0047 | 0597-0047-24 | 1 BOTTLE, PLASTIC in 1 CARTON (0597-0047-24) / 240 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 50MG/5ML | ||||
Approval Date: | Sep 11, 1998 | TE: | RLD: | Yes |
Expired US Patents for NDA 020933
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | VIRAMUNE | nevirapine | SUSPENSION;ORAL | 020933-001 | Sep 11, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription